- Home
- LBRT vs ALVO Comparison
LBRT vs ALVO Comparison
Compare LBRT & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LBRT | ALVO |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 1.0B |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LBRT | ALVO |
|---|---|---|
| Price | $19.34 | $5.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $27.50 | $8.00 |
| AVG Volume (30 Days) | ★ 3.1M | 960.0K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $4,006,116,000.00 | N/A |
| Revenue This Year | $0.27 | $13.28 |
| Revenue Next Year | $7.44 | $18.63 |
| P/E Ratio | $48.68 | ★ $18.20 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.69 | $2.94 |
| 52 Week High | $34.48 | $9.25 |
Technical Indicators
Market Signals| Indicator | LBRT | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 43.64 | 59.64 |
| Support Level | $18.04 | $3.10 |
| Resistance Level | $20.00 | $5.45 |
| Average True Range (ATR) | 0.89 | 0.20 |
| MACD | 0.09 | -0.05 |
| Stochastic Oscillator | 35.93 | 34.59 |
Price Performance
Historical ComparisonAbout LBRT Liberty Energy Inc.
Liberty Energy Inc is a integrated energy services and technology company focused on providing hydraulic fracturing services and related technologies to onshore oil and natural gas exploration and production (E&P) companies. The Company offers customers with hydraulic fracturing services, together with complementary services including wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods (including sand mine operations), and technologies to facilitate lower emission completions, thereby helping customers reduce emissions profile. The company provides services across USA and Canada.
About ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.